Literature DB >> 15894173

Ca2+-independent activation of Bruton's tyrosine kinase is required for store-mediated Ca2+ entry in human platelets.

Pedro C Redondo1, Nidhal Ben-Amor, Ginés M Salido, Aghleb Bartegi, José A Pariente, Juan A Rosado.   

Abstract

Store-mediated Ca(2+) entry (SMCE), which is rapidly activated by depletion of the intracellular Ca(2+) stores, is a major mechanism for Ca(2+) influx. Several studies have involved tyrosine kinases in the activation of SMCE, such as pp60(src), although at present those involved in the early activation steps are unknown. Here we report the involvement of Bruton's tyrosine kinase (Btk) in the early stages of SMCE in human platelets. Cell treatment with thrombin or thapsigargin (TG) plus ionomycin (Iono) results in rapid activation of Btk, which was independent of rise in intracellular Ca(2+) concentration ([Ca(2+)](i)) but dependent on H(2)O(2) generation. Platelet treatment with Btk inhibitors, LFM-A13 or terreic acid, significantly reduced TG+Iono- and thrombin-evoked SMCE. Btk was rapidly activated by addition of low concentrations of H(2)O(2), whose effect on Ca(2+) entry was prevented by Btk inhibitors. Our results indicate that pp60(src) and Btk co-immunoprecipitate after platelet stimulation with TG+Iono, thrombin or H(2)O(2). In addition, we have found that LFM-A13 impaired actin filament reorganization after store depletion and agonist-induced activation of pp60(src), while the inhibitor of pp60(src), a protein that requires actin reorganization for its activation, did not modify Btk activation, suggesting that Btk is upstream of pp60(src). We propose a role for Btk in the early steps of activation of SMCE in human platelets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15894173     DOI: 10.1016/j.cellsig.2004.11.019

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Evaluation of the antiaggregant activity of ascorbyl phenolic esters with antioxidant properties.

Authors:  Esther Lopez; María del Carmen Ortega-Liébana; Sofía Salido; Ginés M Salido; Joaquín Altarejos; Juan A Rosado; Pedro C Redondo
Journal:  J Physiol Biochem       Date:  2015-06-17       Impact factor: 4.158

2.  Store-operated Ca2+ Entry-associated Regulatory factor (SARAF) Plays an Important Role in the Regulation of Arachidonate-regulated Ca2+ (ARC) Channels.

Authors:  Letizia Albarran; Jose J Lopez; Geoffrey E Woodard; Gines M Salido; Juan A Rosado
Journal:  J Biol Chem       Date:  2016-01-27       Impact factor: 5.157

3.  Vaccination prepartum enhances the beneficial effects of melatonin on the immune response and reduces platelet responsiveness in sheep.

Authors:  Sergio Regodón; Asunción Ramos; María P Míguez; Antonio Carrillo-Vico; Juan A Rosado; Isaac Jardín
Journal:  BMC Vet Res       Date:  2012-06-20       Impact factor: 2.741

Review 4.  Role of oxidant scavengers in the prevention of Ca²+ homeostasis disorders.

Authors:  Carmen Galan; Isaac Jardín; Natalia Dionisio; Ginés Salido; Juan A Rosado
Journal:  Molecules       Date:  2010-10-15       Impact factor: 4.411

Review 5.  CRACking the Molecular Regulatory Mechanism of SOCE during Platelet Activation in Thrombo-Occlusive Diseases.

Authors:  Patrick Münzer; Oliver Borst
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

6.  Insulin, insulin resistance, and platelet signaling in diabetes.

Authors:  Voahanginirina Randriamboavonjy; Ingrid Fleming
Journal:  Diabetes Care       Date:  2009-04       Impact factor: 19.112

7.  Dynamic interaction of SARAF with STIM1 and Orai1 to modulate store-operated calcium entry.

Authors:  Letizia Albarran; Jose J Lopez; Nidhal Ben Amor; Francisco E Martin-Cano; Alejandro Berna-Erro; Tarik Smani; Gines M Salido; Juan A Rosado
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

8.  Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload.

Authors:  Matthew T Harper
Journal:  Platelets       Date:  2017-12-01       Impact factor: 3.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.